All Posts:HIV
-
Novel Brain Map Tracks Early Brain Atrophy From HIV Infection
MEDIA CONTACT:Karen Teberkm463@georgetown.edu WASHINGTON (March 28, 2019) — A new map of brain tissue in people with HIV shows atrophy in several areas including a primary neurocognitive control center where shrinkage and loss of function can be seen in scans before clinical symptoms appear. The map and other findings from researchers at Georgetown University Medical […]
Category: News Release
-
A Commitment To Evidence Helps Merenstein Thrive As Physician-Scientist
(February 15, 2019) —As a tenured professor and the director of research programs in the department of family medicine at Georgetown University School of Medicine, Daniel Merenstein, MD, spends most of his time pursuing evidence-based answers to common clinical questions. A major focus of his research that epitomizes this quest involves probiotics — the so-called […]
Category: GUMC Stories
-
Study Finds HIV+ Cancer Patients Benefit From Immunotherapy
MEDIA CONTACT:Karen Teberkm463@georgetown.edu WASHINGTON (February 7, 2019) — The immunotherapy that has revolutionized treatment of many cancers appears to offer similar benefit to cancer patients living with HIV, say researchers at Georgetown Lombardi Comprehensive Cancer Center. Their study, published in JAMA Oncology, focused on whether a relatively new class of drugs called checkpoint inhibitors is both safe and […]
Category: News Release
-
Researchers Offer New Model for Uncovering True HIV Mortality Rates in Zambia
A new study that seeks to better ascertain HIV mortality rates in Zambia could provide a model for improved national and regional surveillance approaches, and ultimately, more effective HIV treatment strategies. The work was conducted by a team of researchers co-led by Charles Holmes, MD, MPH, of Georgetown University Medical Center’s Center for Global Health and Quality and Georgetown’s School of Medicine.
Category: News Release